KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $16.6 million.

  • Acadia Pharmaceuticals' Other Working Capital Changes rose 47.82% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 31.49%. This contributed to the annual value of $16.6 million for FY2024, which is 6.23% down from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $16.6 million for FY2024, which was down 6.23% from $17.7 million recorded in FY2023.
  • Acadia Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $17.7 million during FY2023, with a 5-year trough of -$7.9 million in FY2022.
  • In the last 3 years, Acadia Pharmaceuticals' Other Working Capital Changes had a median value of $16.6 million in 2024 and averaged $8.8 million.
  • In the last 5 years, Acadia Pharmaceuticals' Other Working Capital Changes skyrocketed by 381.49% in 2020 and then crashed by 176.65% in 2021.
  • Over the past 5 years, Acadia Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $7.1 million in 2020, then slumped by 176.65% to -$5.4 million in 2021, then slumped by 45.70% to -$7.9 million in 2022, then spiked by 323.51% to $17.7 million in 2023, then fell by 6.23% to $16.6 million in 2024.